Ingalls & Snyder »

Os Therapies Incorporated shares owned by Ingalls & Snyder

Quarter-by-quarter ownership of Os Therapies Incorporated (OSTX) shares owned by Ingalls & Snyder from 13F filings

Historical chart of Ingalls & Snyder investment in Os Therapies Incorporated

Tip: Access up to 7 years of quarterly data

All positions including Os Therapies Incorporated held by Ingalls & Snyder consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Os Therapies Incorporated by Ingalls & Snyder

Quarter filed Position value Share count Share price at filing
2025-09-30 $72k 37k 1.96
2025-06-30 $69k 37k 1.88
2025-03-31 $56k 37k 1.53

More positions owned by Ingalls & Snyder

Corcept Therapeutics Call Call Option (CORT)
Microsoft Corporation (MSFT)
Apple (AAPL)
Williams Companies (WMB)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Exxon Mobil Corporation (XOM)
Canadian Nat Res Call Call Option (CNQ)
Alphabet Cap Stk Cl A (GOOGL)
Pan American Silver Corp Can (PAAS)
JPMorgan Chase & Co. (JPM)
Amazon (AMZN)
NVIDIA Corporation (NVDA)
Alphabet Cap Stk Cl C (GOOG)
Procter & Gamble Company (PG)
Abbott Laboratories (ABT)

View all positions for Ingalls & Snyder

Top funds holding Os Therapies Incorporated

CM Management
Marshall Wace
Vanguard Group
Geode Capital Management
Millennium Management
Two Sigma Investments
Virtu Financial
Northern Trust
State Street Corporation
BlackRock
Ingalls & Snyder
Bridgeway Capital Management
Ground Swell Capital
Mercer Global Advisors
Stifel Financial

View all funds holding Os Therapies Incorporated